Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
about
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic reviewCombined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II studyGemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer CellsNovel monoclonal antibody against beta 1 integrin enhances cisplatin efficacy in human lung adenocarcinoma cellsPaclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancerThe case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE).Lung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning.Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients.Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.Cost-effectivenes of paclitaxel plus cisplatin in advanced non-small-cell lung cancer.Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancerA randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated.Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer.Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancerUpdate on taxanes in the first-line treatment of advanced non-small-cell lung cancer.Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development.Taxane-induced arthralgia and myalgia: A literature review.Tubulin inhibitors in non-small cell lung cancer: looking back and forward.Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7.Timing of quality of life (QoL) assessments as a source of error in oncological trials.65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer.Chemotherapy for Advanced Non-small Cell Lung Cancer.Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
P2860
Q24678961-ACE7FECA-E568-434F-AC8C-D5809E70D8C8Q28364203-99F2F0FE-A4FF-4438-BB64-D694465E2C15Q28364865-27D53991-A603-43DC-89B0-D604E0EC836EQ28553961-32A047AB-5EAC-4FB2-BCCC-6E9DEAAC4CB3Q28829821-1A0E44BE-F1E8-404E-94F2-0735D7F59714Q31791219-CD514487-9AF2-437F-BD3F-8D55B9700867Q33333677-5AAE8AFB-A86B-4631-A42B-58880660ACCBQ33334597-186F768B-0544-4DC2-8C7C-7ADFF56E09A1Q33341156-F8FE5B83-165F-48F1-AA47-0B8CB4311376Q33341208-22E5F793-6DD9-472F-BC16-C731DCA23BDFQ34562736-51650665-4A0D-40C5-A6B8-97B751167BCCQ34594899-6E083D92-0A1D-4D38-86EC-3D0E99F69939Q34791240-1A1CC00F-EC2B-479A-9E08-935F8D671685Q35096015-A37115E2-1B24-4874-A2E0-9D608B376DC2Q36299985-905424DB-B2EA-4996-BD62-80A2857FD1D2Q36614907-86A4FF52-C323-4FC2-AA5B-9B523EE7B572Q36617642-7764F881-C08E-421A-B29A-DD958494D162Q36619609-84DD247A-4A0F-4328-9737-72BAB44B5B9EQ36694403-22DD9201-3CAF-40EF-8310-84FA2B4AC8EFQ36975137-C98531A1-97A4-40DF-A4FF-FD617CFA9A1FQ37355007-74B2A929-04EB-4886-85AD-2D490F331555Q38258744-6EE4BBAC-1A12-4EAD-875A-828246B0D76AQ38602994-95FDB9D0-7BE3-4C91-AA96-3923F9343524Q38711952-9F05D5C0-1245-4FA7-9D1E-B60485082EBDQ38742506-7C53037C-8C71-46F9-A913-EFA924C6B8E4Q42109363-1173ACB8-42A9-428A-9E8B-1A4602656B4AQ43724371-B7875E50-2F88-408B-81A4-748A0AB2547BQ47104104-2EB25FB9-0FA6-4663-84CD-2ABC4E7E6603Q52853807-A3B908BD-3512-4748-9A40-7C73C55FDF7DQ54672469-76D688E4-FDB6-41AF-A3B0-97B3240B4EF6
P2860
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Randomized study of paclitaxel ...... Lung Cancer Cooperative Group.
@ast
Randomized study of paclitaxel ...... Lung Cancer Cooperative Group.
@en
type
label
Randomized study of paclitaxel ...... Lung Cancer Cooperative Group.
@ast
Randomized study of paclitaxel ...... Lung Cancer Cooperative Group.
@en
prefLabel
Randomized study of paclitaxel ...... Lung Cancer Cooperative Group.
@ast
Randomized study of paclitaxel ...... Lung Cancer Cooperative Group.
@en
P2093
P1476
Randomized study of paclitaxel ...... Lung Cancer Cooperative Group.
@en
P2093
C Debruyne
G Giaccone
G Scagliotti
J van Meerbeeck
M C Pennucci
N van Zandwijk
P E Postmus
Q van Hoesel
P304
P356
10.1200/JCO.1998.16.6.2133
P407
P577
1998-06-01T00:00:00Z